Fluoroquinolone Toxicity Study, formerly known as The Foundation for Fluoroquinolones Toxicity Study and Research, was recognized exclusively as a charitable 501(c)(3) nonprofit organization under Federal Tax Exemption and Illinois Sales and Use Tax Exemption on October 07, 2015.
The Foundation was the first known to have organized both a human in vivo and in vitro study for fluoroquinolone genomic and mitochondrial DNA adducts. Our organization sent our 2017 research study results to scientists and governments around the world as well as to the FDA, EPA, EMA, WHO, US Health Department, global Ministries of Health, members of Congress, Senate and the White House. Cooperation between the European Medicines Agency (EMA) and the Pharmacovigilance Risk Assessment Committee (PRAC), contributed to the message about the possibility of mitochondrial damage being conveyed to European citizens, the medical community and referenced in the PRAC 2018 report.
Vision
The Foundation was created to explore a path to recovery for the masses of drug damaged victims around the world. By funding our own research studies and conveying those findings to the medical and science communities, we hope to create change in how these drugs are used.
Our Mission
To drive collaborative research at the cellular & molecular levels, aimed to identify the mechanism of damage induced by the fluoroquinolone class of antibiotics. Building upon these study findings, we anticipate the identification of preventive, diagnostic, and therapeutic treatments and approaches.
Donation
If you would like to make a donation towards continued research, it is greatly appreciated. We would like to thank everyone who made even the smallest donation.
